+46.1%
GSK vs EQH
+100.2%
-54.1%
-28.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | EQH | Excess | Alpha |
|---|---|---|---|---|
| 1D | 0.0% | +1.4% | -1.4% | -0.1% |
| 7D | -3.5% | +0.7% | -4.2% | -3.6% |
| 30D | -3.4% | +2.8% | -6.3% | -3.6% |
| 3M | -8.1% | +23.1% | -31.2% | -9.1% |
| 6M | -11.1% | +41.4% | -52.5% | -12.7% |
| YTD | +0.7% | +14.3% | -13.5% | -0.3% |
| 1Y | +20.1% | +1.6% | +18.5% | +19.4% |
| 3Y | +46.1% | +102.7% | -56.6% | +34.6% |
| All | +46.1% | +100.2% | -54.1% | +34.6% |
Cumulative growth
Daily Returns
Daily percentage return beside EQH.
Daily Out/Under-Performance
Portfolio return minus EQH return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EQH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded EQH wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling